Bioscience
TriSalus Life Sciences launches TriNav Infusion System to overcome infusion barriers in tumors
DENVER -- TriSalus Life Sciences announced the launch of its TriNav Infusion System. Powered by its proprietary Pressure-Enabled Drug DeliveryTM (PEDD) approach with SmartValveTM technology,... Read More
Thursday January 16, 2020 0 comments
ArcherDX Personalized Cancer Monitoring (PCM) tech designated by FDA as Breakthrough Device
BOULDER -- ArcherDX, Inc. announced it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Personalized Cancer Monitoring (PCM) technology, a... Read More
Wednesday January 15, 2020 0 comments
Clovis Oncology’s Rubraca granted FDA priority review for advanced prostate cancer
BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the U.S. Food and Drug Administration (FDA) has accepted the companys supplemental New Drug Application (sNDA) for Rubraca ... Read More
Wednesday January 15, 2020 0 comments
PanTheryx announces new CEO and board chair
BOULDER -- PanTheryx announced CEO Mark Braman is retiring and nutrition industry veteran Wes Parris, formerly of I-Health, Inc., will replace Braman as CEO effective immediately. PanTheryx... Read More
Tuesday January 14, 2020 0 comments
ArcherDX and Illumina partner to broaden access for oncology testing
BOULDER -- ArcherDX, Inc . announced a non-exclusive, multi-year partnership with San Diego-based Illumina, Inc. (NASDAQ: ILMN) that aims to broaden access of next generation sequencing (NGS)-based... Read More
Monday January 13, 2020 0 comments
Cerebral Therapeutics completes $35M Series B financing round
AURORA -- Cerebral Therapeutics , a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, today announced a$35 millionSeries B financing led... Read More
Tuesday January 7, 2020 0 comments
ArcherDX appoints Mark Massaro company CFO
BOULDER -- ArcherDX, Inc. , a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has... Read More
Tuesday January 7, 2020 0 comments
Colorado life sciences companies raise $750M in 2019, Pfizer acquisition of Array BioPharma brings total to $12.1B
DENVER -- Colorados life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of... Read More
Wednesday December 18, 2019 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
